(in Barosi/Spivak et al). Probability of death, cardiovascular death, and hematological progression-free survival of 1638 patients with polycythemia vera recruited in the European Collaboration on Low-dose Aspirin in Polycythemia Vera (ECLAP) study.
Sign In or Create an Account